AAA
QTTB icon

Affinity Asset Advisors’s Q32 Bio QTTB Stock Holding History

Affinity Asset Advisors’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$354K Hold
27,777
– – 0.02% 109
2026
Q1 		$178K Hold
27,777
– – 0.01% 103
2025
Q4 		$92.2K Hold
27,777
– – 0.01% 93
2025
Q3 		$55K Hold
27,777
– – ﹤0.01% 94
2025
Q2 		$41.4K Hold
27,777
– – 0.01% 88
2025
Q1 		$45.8K Hold
27,777
– – ﹤0.01% 96
2024
Q4 		$95.6K Hold
27,777
– – 0.01% 81
2024
Q3 		$1.24M Hold
27,777
– – 0.17% 71
2024
Q2 		$499K Hold
27,777
– – 0.06% 88
2024
Q1 		$473K Buy
+27,777
New +$383K 0.06% 89

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Affinity Asset Advisors's QTTB Position: Q2 2026 in Review

Affinity Asset Advisors held its Q32 Bio (QTTB) position steady in Q2 2026 at 27,777 shares worth $354K. The position accounts for 0.02% of the portfolio, ranked #109.

Affinity Asset Advisors first reported a position in QTTB in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.24M in Q3 2024. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Affinity Asset Advisors held 27,777 shares of Q32 Bio worth $354K as of Q2 2026.
  • Affinity Asset Advisors left its Q32 Bio share count unchanged in Q2 2026.
  • Q32 Bio made up 0.02% of Affinity Asset Advisors's portfolio in Q2 2026, its #109 holding.
  • Affinity Asset Advisors first reported a position in Q32 Bio in Q1 2024 and has held it in 10 quarters since.
  • Affinity Asset Advisors's Q32 Bio position peaked at $1.24M in Q3 2024.
  • 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Affinity Asset Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.